Discovery and Validation of a Metastasis-Related Prognostic and Diagnostic Biomarker for Melanoma Based on Single Cell and Gene Expression Datasets
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discovery and Validation of a Metastasis-Related Prognostic and Diagnostic Biomarker for Melanoma Based on Single Cell and Gene Expression Datasets
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-11-25
DOI
10.3389/fonc.2020.585980
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Methylation analysis highlights novel prognostic criteria in human-metastasized melanoma
- (2019) Weiyang Cai et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The Extracellular Matrix Modulates the Metastatic Journey
- (2019) FuiBoon Kai et al. DEVELOPMENTAL CELL
- Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma
- (2019) Antoni Ribas et al. NATURE MEDICINE
- HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target
- (2019) Souri et al. Cancers
- Development and validation of a metastasis-associated prognostic signature based on single-cell RNA-seq in clear cell renal cell carcinoma
- (2019) Chuanjie Zhang et al. Aging-US
- EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration
- (2018) Nicole M. Aiello et al. DEVELOPMENTAL CELL
- Thyroid cancer stem-like cell exosomes: regulation of EMT via transfer of lncRNAs
- (2018) Heather Hardin et al. LABORATORY INVESTIGATION
- The brim of uncertainty in adjuvant treatment of melanoma
- (2018) Allison Betof Warner et al. LANCET ONCOLOGY
- Neoadjuvant therapy in melanoma: the next step?
- (2018) Paolo A Ascierto et al. LANCET ONCOLOGY
- DKK2 imparts tumor immunity evasion through β-catenin-independent suppression of cytotoxic immune-cell activation
- (2018) Qian Xiao et al. NATURE MEDICINE
- More on Adjuvant Therapy in Resected Melanoma
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
- (2018) Deng Pan et al. SCIENCE
- Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas
- (2018) Nicolas Jonckheere et al. Journal of Translational Medicine
- A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
- (2018) Livnat Jerby-Arnon et al. CELL
- Survival of patients with advanced metastatic melanoma: the impact of novel therapies–update 2017
- (2017) Selma Ugurel et al. EUROPEAN JOURNAL OF CANCER
- A Two-Gene Prognostic Classifier for Early-Stage Lung Squamous Cell Carcinoma in Multiple Large-Scale and Geographically Diverse Cohorts
- (2017) Rintaro Noro et al. Journal of Thoracic Oncology
- Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
- (2017) Mark B. Faries et al. NEW ENGLAND JOURNAL OF MEDICINE
- BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival
- (2016) Emilia Hugdahl et al. BRITISH JOURNAL OF CANCER
- SerpinE2 promotes multiple cell proliferation and drug resistance in osteosarcoma
- (2016) MINZHI MAO et al. Molecular Medicine Reports
- Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
- (2016) Bowen Du et al. MOLECULES
- Twist2 promotes kidney cancer cell proliferation and invasion by regulating ITGA6 and CD44 expression in the ECM-receptor interaction pathway
- (2016) Tong-yu Zhu et al. OncoTargets and Therapy
- The Genetic Evolution of Melanoma from Precursor Lesions
- (2015) A. Hunter Shain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy
- (2015) Helena Cirenajwis et al. Oncotarget
- Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells
- (2015) Kyu-Tae Kim et al. GENOME BIOLOGY
- DUSP6 regulates drug sensitivity by modulating DNA damage response
- (2013) T V Bagnyukova et al. BRITISH JOURNAL OF CANCER
- Transcriptome Profiling Identifies HMGA2 as a Biomarker of Melanoma Progression and Prognosis
- (2013) Leon Raskin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- CTGF is a therapeutic target for metastatic melanoma
- (2013) E C Finger et al. ONCOGENE
- Upcoming strategies for the treatment of metastatic melanoma
- (2012) Francesco Spagnolo et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells
- (2012) Debora Degl'Innocenti et al. ENDOCRINE-RELATED CANCER
- Melanoma genome sequencing reveals frequent PREX2 mutations
- (2012) Michael F. Berger et al. NATURE
- Single-cell sequencing analysis characterizes common and cell-lineage-specific mutations in a muscle-invasive bladder cancer
- (2012) Yingrui Li et al. GigaScience
- Dual-specificity phosphatase DUSP6 has tumor-promoting properties in human glioblastomas
- (2011) S Messina et al. ONCOGENE
- Integrative Genome Comparison of Primary and Metastatic Melanomas
- (2010) Omar Kabbarah et al. PLoS One
- Gene Expression Changes in an Animal Melanoma Model Correlate with Aggressiveness of Human Melanoma Metastases
- (2008) L. Xu et al. MOLECULAR CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started